Sponsors
The bill increases drug-price and PBM transparency and expands access to association health plans to lower costs and improve consumer visibility, but it also raises compliance costs, privacy and enforcement risks, and may weaken benefit comprehensiveness and state-level consumer protections.
Small employers and self-employed individuals can join or form multi-employer association health plans (AHPs), expanding access to group coverage and prohibiting denial or higher premiums based on health status for enrollees.
PBMs and plans must provide standardized, machine-readable reports (net/gross prices, rebates, pharmacy payments) and participant-facing summaries, giving plans and employers clearer drug-price information to negotiate better contracts and control prescription spending.
Participants (patients) can request participant-facing summaries and claim-level information that explain out-of-pocket costs and the difference between amounts paid to PBMs and pharmacies, improving consumer visibility into drug costs.
Employees and dependents in association health plans may face narrower benefits or less comprehensive provider networks and increased coverage instability, and expanded federal preemption could limit state consumer protections.
Frequent, detailed reporting and registration requirements will raise administrative and compliance costs for PBMs, plans, and employers, costs that are likely to be passed to consumers via higher premiums, fees, or reduced benefits.
Detailed, claims-level and machine-readable reporting increases risks of sensitive health data exposure or reidentification despite HIPAA/HITECH limits, creating privacy concerns for patients with identifiable prescription patterns.
Based on analysis of 5 sections of legislative text.
Allows cross‑industry employer associations to offer association health plans and imposes extensive PBM registration, price/rebate disclosure, and reporting requirements to plans, HHS, GAO, and the IRS.
Allows employer associations to form and offer association health plans (AHPs) across industries if they meet new formation, governance, membership, and plan-control rules, and creates extensive federal transparency, disclosure, and reporting requirements for pharmacy benefit managers (PBMs). PBMs must register, provide semiannual (or quarterly on request) machine-readable and plain-language reports to plans with drug-level claims and financial data, and cannot use contract terms that block required disclosures; parallel reporting and enforcement requirements are added across ERISA, the Public Health Service Act, and the Internal Revenue Code. PBM reporting and many disclosure requirements take effect for plan years beginning 30 months after enactment; AHP rule changes apply upon enactment unless otherwise specified.
Introduced December 15, 2025 by Mariannette Miller-Meeks · Last progress December 18, 2025